Cannabis and Pain Management.

J Am Board Fam Med

From the Family Medicine and Addiction Medicine, SSM Health SLUCare and Saint Louis University School of Medicine (FR); Family Medicine and Addiction Medicine, SSM Health SLUCare and Saint Louis University School of Medicine (SL); Saint Louis University School of Medicine (JH); Anesthesiology and Critical Care, SSM Health SLUCare and Saint Louis University School of Medicine (GP); Family Medicine and Addiction Medicine, SSM Health SLUCare and Saint Louis University School of Medicine (AH).

Published: October 2024

Family physicians are fielding questions about cannabis --particularly for the use of cannabis for treatment of pain. Like about every substance ingested to treat medical conditions, cannabis has risks and benefits. But regarding evidence-based practice and practice-based recommendations for patients about cannabis use, the cart is in front of the horse. Cannabis use is still illegal at a federal level and a Schedule 1 drug, but most states have challenged federal law by decriminalizing or legalizing cannabis for a variety of uses. Research is difficult due to this federal status as a Schedule 1 drug since federal funding is not readily available to support research. As a result, physicians have little to no guidance about the clinical usefulness of the product. This article explores what we know and what we are learning about cannabis, and the authors provide clinical guidance for patient care based on this evidence.

Download full-text PDF

Source
http://dx.doi.org/10.3122/jabfm.2023.230462R1DOI Listing

Publication Analysis

Top Keywords

cannabis
8
schedule drug
8
cannabis pain
4
pain management
4
management family
4
family physicians
4
physicians fielding
4
fielding questions
4
questions cannabis
4
cannabis --particularly
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!